In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...
Biogen (BIIB) announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and ...
Hosted on MSN1mon
Why Biogen Inc. (BIIB) Is Among the Best Healthcare Stocks To Buy According to AnalystsIn this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare industry witnessed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback